Core Medical Technology
Series D in 2025
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
LYNK Pharmaceuticals
Series C in 2023
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.
Core Medical Technology
Series C in 2022
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
Indiemicro
Series B in 2022
Indie microelectronics combines R&D, testing, platform development, application development, technical support, and sales centers. Sales and technical support centers have been established in Shanghai, Shenzhen, and Taipei with a focus on supporting semiconductor products for Great China customers.
Angstrong
Series B in 2022
Angstrong Tech is a developer and manufacturer specializing in 3D sensing and smart hardware solutions. Headquartered in Shenzhen, with additional branches in Shanghai and the United States, the company focuses on creating advanced 3D sensing technology for diverse applications across various industries. These include mobile phones, personal computers, security surveillance, facial recognition, smart driving, medical technology, and smart homes. Angstrong's innovations enhance user experiences in areas such as augmented and virtual reality, robotic operations, and smart retail. The company's commitment to quality and innovation positions it as a leader in the smart hardware market.
LYNK Pharmaceuticals
Series B in 2021
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.
MediTrust Health
Series C in 2021
MediTrust Health is a leading healthcare platform in China that offers a wide range of health insurance products and comprehensive medical services. The company connects pharmaceutical companies, insurers, hospitals, and patients, creating a cohesive ecosystem that benefits all stakeholders involved. By integrating high-quality medical resources with health insurance, MediTrust Health aims to deliver affordable, personalized healthcare solutions to families. In addition to its insurance offerings, the company focuses on improving the management of medical expenses and enhancing patient access to necessary services through innovative payment solutions. MediTrust Health's commitment to addressing the complexities of medical financing and providing diverse healthcare benefits positions it as a significant player in the healthcare industry.
Infervision
Series D in 2021
Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.
Biotheus Inc. is a biotechnology company based in Zhuhai, China, founded in 2018. The company specializes in the development and commercialization of innovative biologics, focusing primarily on monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals. Biotheus is dedicated to addressing malignant tumors and autoimmune diseases by researching and developing next-generation multispecific antibodies. The company explores the mechanisms of regulatory T cells and innate immunity to create antibody-based therapeutics that enhance immune therapy and provide effective treatments for cancer and metabolic disorders.
CapitalBio Technology
Private Equity Round in 2021
CapitalBio Technology, established in 2012, is a leading life science company based in Beijing, China. It specializes in developing and commercializing a wide array of healthcare solutions, including diagnostic kits for respiratory pathogens, hepatitis B, and thalassemia, as well as a broad spectrum of microarray and microfluidic chips, related instruments, software, databases, reagents, and consumables. These products cater to diverse customers, from biomedical researchers to healthcare professionals, serving applications in basic research, drug development, clinical diagnostics, biosafety, food safety, and molecular breeding. CapitalBio Technology also offers services such as Special Needs Plans (SNP) service, mRNA Expression Profiling Service, DNA methylation detection service, and sequencing services. As a subsidiary of CapitalBio Corporation and the Biological Chip Beijing National Engineering Research Center, it employs over 500 highly educated professionals, with 86% holding at least a Bachelor's degree, including 14 doctors or post-doctorates.
InnoGrit Corporation
Series B in 2020
InnoGrit Corporation is a technology company that specializes in developing and marketing advanced data storage and transport solutions tailored for artificial intelligence and big data applications. Founded in 2016 by Zining Wu, InnoGrit is headquartered in Shanghai, China, with additional offices in Chengdu and San Jose, California. The company offers a range of PCIe Gen 3 and Gen 4 solid-state drive (SSD) processors, including models like Rainier, Shasta, Tacoma, and Shasta+, designed for enterprise and client applications. InnoGrit's innovative processors aim to enhance the speed and efficiency of data handling, reduce network latency, and facilitate smoother data transport by integrating storage, networking, and computational functions. Additionally, InnoGrit provides comprehensive support to its clients, addressing the growing demands for data backup and distribution across various sectors, including cloud computing and data warehousing.
Sight Diagnostics
Series D in 2020
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that specializes in blood diagnostics using advanced computer vision technology. The company focuses on improving health outcomes with rapid, accurate, and convenient diagnostic solutions. His flagship product, Parasight, is a malaria detection device that has performed nearly one million tests across 24 countries, though it is not available for sale in the United States. Sight Diagnostics has also developed Sight OLO, an FDA-cleared blood analyzer that requires only two drops of blood to deliver lab-grade Complete Blood Count results within minutes. Combining machine vision, AI, and innovations in multiple scientific fields, Sight Diagnostics aims to facilitate effective healthcare delivery and expand its commercial presence across five continents.
Biotheus Inc. is a biotechnology company based in Zhuhai, China, founded in 2018. The company specializes in the development and commercialization of innovative biologics, focusing primarily on monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals. Biotheus is dedicated to addressing malignant tumors and autoimmune diseases by researching and developing next-generation multispecific antibodies. The company explores the mechanisms of regulatory T cells and innate immunity to create antibody-based therapeutics that enhance immune therapy and provide effective treatments for cancer and metabolic disorders.
CapitalBio Technology
Series C in 2020
CapitalBio Technology, established in 2012, is a leading life science company based in Beijing, China. It specializes in developing and commercializing a wide array of healthcare solutions, including diagnostic kits for respiratory pathogens, hepatitis B, and thalassemia, as well as a broad spectrum of microarray and microfluidic chips, related instruments, software, databases, reagents, and consumables. These products cater to diverse customers, from biomedical researchers to healthcare professionals, serving applications in basic research, drug development, clinical diagnostics, biosafety, food safety, and molecular breeding. CapitalBio Technology also offers services such as Special Needs Plans (SNP) service, mRNA Expression Profiling Service, DNA methylation detection service, and sequencing services. As a subsidiary of CapitalBio Corporation and the Biological Chip Beijing National Engineering Research Center, it employs over 500 highly educated professionals, with 86% holding at least a Bachelor's degree, including 14 doctors or post-doctorates.
Shanghai Data Exchange
Series A in 2020
Shanghai Data Exchange Corp. is a prominent platform based in Shanghai, China, focused on the circulation and interconnection of commercial data. The company aims to establish itself as a pivotal hub for global data element configuration, providing efficient and secure transaction services for data circulation. It facilitates cross-regional institutional cooperation and integrates government and business data to enhance data supply and foster new digital commerce formats. Additionally, Shanghai Data Exchange is dedicated to developing a comprehensive digital business system and a fully digital data transaction system, which includes data product registration and management. Through these initiatives, the company seeks to promote the integration of Chinese digital assets into the global data ecosystem.
Westwell Lab
Series C in 2020
Westwell Lab is a Shanghai-based commercial laboratory established in 2015, focusing on the development of neuromorphic circuits and systems. The company specializes in creating advanced AI chips and autopilot systems utilizing neuromorphic engineering and monomer machine learning. By integrating innovative algorithms and custom silicon, Westwell Lab aims to deliver efficient and adaptable AI applications for various industries, including port-control systems, smart mining, and medical analysis. With a biology-inspired approach, the company seeks to enhance big data processing and embedded systems, positioning itself as a leader in the field of unconventional AI technologies.
QST Corporation
Series B in 2020
QST Corporation, founded in September 2012 and headquartered in Shanghai, China, specializes in the development and manufacturing of micro-electromechanical system (MEMS) smart sensors. The company focuses on designing high-quality sensor solutions for mobile consumer electronic devices, including smartphones, tablets, wearables, and augmented/virtual reality headsets. Its product offerings include 3-axis magnetic sensors, accelerometers, gyroscopes, barometers, pressure sensors, and light sensors, as well as combined inertial sensors. QST Corporation aims to customize intelligent applications and services for its clients, leveraging the domestic industrial support system in China to achieve rapid growth. The company is positioned to serve various sectors, including IoT applications, smart homes, and drones, contributing to the advancement of intelligent mobile terminals.
CF PharmTech
Series E in 2020
CF PharmTech, Inc. is an independent specialty pharmaceutical company founded in 2007 and headquartered in Suzhou, China. The company specializes in the development and manufacturing of inhalation products, including metered dose inhalers, dry powder inhalers, nasal sprays, and nebulizers. CF PharmTech focuses on creating high-quality and affordable medications for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. In addition to its product development efforts, the company provides contract manufacturing organization (CMO) services, enhancing its capabilities in the global market. With a commitment to effective patient care, CF PharmTech aims to improve management of respiratory conditions through its innovative offerings.
360 is an internet and security service company that creates 360 Security Guard, 360 Mobile Guard, 360 Security Browser, and other security solutions. 360 is headquartered in Beijing, China and was founded in 2017.
Beijing DeepWise Science And Technology Co., Ltd. is a company that specializes in developing artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and located in Beijing, China, DeepWise focuses on early screening and diagnosis of various malignant diseases, including lung and breast cancers. Its AI-driven software improves efficiency and diagnostic accuracy in healthcare, offering solutions to hospitals, medical centers, and imaging centers. The company's technology supports the online reading and consultation of medical images, leveraging big data in the cloud to facilitate timely and accurate disease detection and treatment.
Innoviz Technologies
Series C in 2019
Innoviz Technologies designs and manufactures solid-state LiDAR sensors and develops perception software to facilitate the mass-production of autonomous vehicles. The company produces InnovizPro, a solid-state LiDAR known for its performance and value in automotive applications, and InnovizOne, an advanced LiDAR sensor providing 3D sensing capabilities essential for Level 3-Level 5 autonomous driving. Additionally, Innoviz offers products for object identification, tracking, sensor fusion, mapping, and localization. Founded in 2016 and based in Rosh HaAyin, Israel, Innoviz has formed strategic alliances with notable investors including Magna International, Samsung, Aptiv, Magma Venture Partners, Vertex Ventures, SoftBank Ventures Asia, China Merchants Capital, 360 Capital Partners, Glory Ventures, Naver, Shenzhen Capital Group, New Alliance Capital, Harel Insurance Investments and Financial Services, Phoenix Insurance Company.
Innoviz Technologies
Series C in 2019
Innoviz Technologies designs and manufactures solid-state LiDAR sensors and develops perception software to facilitate the mass-production of autonomous vehicles. The company produces InnovizPro, a solid-state LiDAR known for its performance and value in automotive applications, and InnovizOne, an advanced LiDAR sensor providing 3D sensing capabilities essential for Level 3-Level 5 autonomous driving. Additionally, Innoviz offers products for object identification, tracking, sensor fusion, mapping, and localization. Founded in 2016 and based in Rosh HaAyin, Israel, Innoviz has formed strategic alliances with notable investors including Magna International, Samsung, Aptiv, Magma Venture Partners, Vertex Ventures, SoftBank Ventures Asia, China Merchants Capital, 360 Capital Partners, Glory Ventures, Naver, Shenzhen Capital Group, New Alliance Capital, Harel Insurance Investments and Financial Services, Phoenix Insurance Company.
Sight Diagnostics
Series C in 2019
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that specializes in blood diagnostics using advanced computer vision technology. The company focuses on improving health outcomes with rapid, accurate, and convenient diagnostic solutions. His flagship product, Parasight, is a malaria detection device that has performed nearly one million tests across 24 countries, though it is not available for sale in the United States. Sight Diagnostics has also developed Sight OLO, an FDA-cleared blood analyzer that requires only two drops of blood to deliver lab-grade Complete Blood Count results within minutes. Combining machine vision, AI, and innovations in multiple scientific fields, Sight Diagnostics aims to facilitate effective healthcare delivery and expand its commercial presence across five continents.
Thousand Oaks Biopharmaceuticals
Series A in 2019
Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and headquartered in Haimen, China, specializes in contract development and manufacturing services for the biotechnology industry. The company focuses on developing technologies to produce protein and vaccine compounds, offering integrated control solutions that optimize processes, increase protein expression, and reduce production scale. Thousand Oaks provides personalized, chemically defined cell culture media, formula production, technical support, and ancillary services to its clients in the biopharmaceutical sector.
Ping An Good Doctor
Series F in 2018
Ping An Health Internet is a wholly owned subsidiary of China Ping An Group, an important member of the Internet business segment/. It was established in August 2014 with 350 million yuan registered capital and is headquartered in Shanghai, China. Companies around the network of doctors, drug network and information network formed three product lines, involving online inquiry, a plurality of segments of the doctor-patient health care management, drug O2O, electronic health records, chronic disease management, child health services. Chinese company to the mobile Internet era medical wisdom of the leader as the goal, to create a user-stop health management solutions provider, China's largest Internet to build a healthy industry ecosystem. Ping An Health Internet also developed a children's health management and chronic disease management, and other vertical applications, to meet the needs of market segments. Reform the health care system combined with the trend, the company vigorously promote the integration of physician resources.
Fusion
Venture Round in 2018
Fusion is a high-tech enterprise company that specializes in new electronic and silver pastes. It also focuses on PV silver paste, filter paste, conductive adhesive, semiconductor, and 5G materials. In addition to the positive silver paste, the company is also actively developing other silver paste products for non-photovoltaic fields. Fusion was founded on August 2015 and is headquartered in Shanghai, China.
ShopEx is a leading e-commerce software and service provider based in China, specializing in the research and development of solutions tailored for online retail. The company offers a comprehensive suite of management software designed to assist retail merchants in various aspects of their operations, including online transactions, supply chain management, and financial payments. By integrating third-party resources, ShopEx enables retail store owners to effectively develop and manage their e-commerce businesses. With a strong focus on innovation, the company boasts an experienced team that has developed proprietary technology and holds intellectual property rights in the field of e-commerce software.
Banma Kuaipao
Series C in 2017
Wuhan Banma Kuaipao Technology Co., Ltd. is a Chinese technology company that focuses on developing mobile applications for transportation services. Founded in July 2015 by Li Jia, the company is headquartered in Wuhan, China. Banma Kuaipao specializes in freight transportation through its mobile application, while also offering services for booking cabs and buses. Its platform caters to a variety of transportation needs, providing users with customized travel options that include commercial vehicles, passenger cars, and buses.
CooTek, founded in 2008 and headquartered in Shanghai, is a global mobile internet company that specializes in developing innovative mobile applications and artificial intelligence technologies. The company is best known for its flagship app, TouchPal Keyboard, which enhances input experiences for users on both Android and iPhone devices. CooTek's diverse portfolio includes content-rich applications across various categories, such as online literature, mobile games, and scenario-based apps focused on fitness, healthcare, and lifestyle. With a significant presence in the United States, CooTek has achieved a broad user base, boasting an average of 213.7 million monthly active users globally as of September 2018. The company is committed to technological innovation, holding over 170 patents and actively pursuing advancements in artificial intelligence through its dedicated AI lab and big data development center in Silicon Valley. CooTek's research has been recognized in prominent discussions at major big data and AI conferences.
Sight Diagnostics
Series B in 2016
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that specializes in blood diagnostics using advanced computer vision technology. The company focuses on improving health outcomes with rapid, accurate, and convenient diagnostic solutions. His flagship product, Parasight, is a malaria detection device that has performed nearly one million tests across 24 countries, though it is not available for sale in the United States. Sight Diagnostics has also developed Sight OLO, an FDA-cleared blood analyzer that requires only two drops of blood to deliver lab-grade Complete Blood Count results within minutes. Combining machine vision, AI, and innovations in multiple scientific fields, Sight Diagnostics aims to facilitate effective healthcare delivery and expand its commercial presence across five continents.
Zhaoxin
Venture Round in 2016
Shanghai Zhaoxin Semiconductor Co., Ltd. specializes in the design and manufacture of core processor chips, including central processing units, graphics processing units, and supporting chipsets. Established in 2013, the company is headquartered in Shanghai and has additional offices in major cities such as Beijing, Wuhan, Shenzhen, and Xi’an. Zhaoxin focuses on delivering high-performance and reliable general-purpose processors through independent innovation while maintaining compatibility with mainstream development routes. Utilizing advanced lithography processes, including 40nm and 28nm technologies, the company develops a range of intelligent terminal processor chips, notably the ARM Cortex AX series and various System on Chip (SoC) products within its Elite series.
KanS is a cosmetics company that specializes in consumer goods, particularly personal care. It is a scientific anti-aging skin care brand that specializes in Asian skin beauty. It uses scientific research to shape product strength and is committed to providing young consumers with Scientific and professional, precise and efficient skin anti-aging solutions. It is supported by dual scientific research laboratories in China and Japan, as well as a high-quality supply chain system.
UnionPay International
Venture Round in 2015
UnionPay International Co., Ltd. is a Shanghai-based subsidiary of China UnionPay that specializes in electronic payment services for cardholders and merchants both in China and globally. Established in 2012, the company offers a range of products including debit and credit cards, mobile and online payment solutions, chip cards, and mobile point-of-sale (mPOS) terminals. UnionPay International partners with over 300 institutions worldwide, enabling card acceptance in 148 countries and regions outside the Chinese mainland and facilitating card issuance in more than 30 locations. The company focuses on providing secure and cost-effective cross-border payment services, meeting the needs of the world's largest cardholder base while ensuring convenient local services for UnionPay cardholders and merchants.